ArticleMaterials today. Bio2026

Chitosan-based nanotheranostics integrated dual-modal imaging and combinatorial tumor therapy for EGFR-TKI resistance reversal.

Fangying Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.